Stimcell Energetics (STME) Net Cash Flow Growth (5y) (2016 - 2026)
Stimcell Energetics (STME) Net Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -88.31% |
| Nov 30, 2025 | 19.22% |
| Aug 31, 2025 | -16.08% |
| May 31, 2025 | 16.14% |
| Feb 28, 2025 | 30.05% |
| Nov 30, 2024 | 16.79% |
| Aug 31, 2024 | -15.75% |
| May 31, 2024 | 12.03% |
| Feb 29, 2024 | -11.97% |
| Nov 30, 2023 | -54.42% |
| Aug 31, 2023 | -57.17% |
| May 31, 2023 | 51.40% |
| Feb 28, 2023 | 33.94% |
| Nov 30, 2022 | 15.33% |
| Aug 31, 2022 | -15.52% |
| May 31, 2022 | -16.09% |
| Feb 28, 2022 | 42.79% |
| Nov 30, 2021 | -18.38% |
| Aug 31, 2021 | 32.30% |
| May 31, 2021 | -18.90% |